NASDAQ:PTGX – State Reviewer

Stock Earnings

Protagonist (PTGX) Stock Experiences Bullish Trend Amidst Index Inclusion

Upon news of its inclusion in S&P index, Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stock is experiencing a notable uptick on the US charts today. PTGX

Finance

Are Protagonist Therapeutics Inc. (NASDAQ:PTGX) Prospects Worsening?

Protagonist Therapeutics Inc. (NASDAQ:PTGX) shares traded higher over the last trading session, gaining 9.33% on 06/16/21. The shares fell to a low of $39.50 before

Companies

Analyst’s Sets Protagonist Therapeutics Inc. (NASDAQ:PTGX) New Target at $39.57: PTGX is Now On A Buy List

Protagonist Therapeutics Inc. (NASDAQ:PTGX) has a beta of 1.55. The stock’s Relative Strength Index (RSI) is 53.64, with weekly volatility at 5.86% and ATR at

Companies

Protagonist Therapeutics Inc. (PTGX) move up 0.92% this morning: PTGX Price Rally Looks Real

Protagonist Therapeutics Inc. (NASDAQ:PTGX) shares traded higher over the last trading session, gaining 0.92% on 05/27/21. The shares fell to a low of $33.59 before

Tag: NASDAQ:PTGX

Protagonist (PTGX) Stock Experiences Bullish Trend Amidst Index Inclusion

Are Protagonist Therapeutics Inc. (NASDAQ:PTGX) Prospects Worsening?

Analyst’s Sets Protagonist Therapeutics Inc. (NASDAQ:PTGX) New Target at $39.57: PTGX is Now On A Buy List

Protagonist Therapeutics Inc. (PTGX) move up 0.92% this morning: PTGX Price Rally Looks Real

Quick Links

Categories